Approval · Notice of Compliance 4305 · 1996

CEFTIN: Notice of Compliance 4305

Issued February 26, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4305
Date: February 26, 1996
Company: Glaxo Wellcome Inc.Mississauga, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Antibiotic

Products in this notice

Brand	DIN	Status today
CEFTIN	02212277	Cancelled Post Market
CEFTIN	02212285	Cancelled Post Market
CEFTIN	02212293	Cancelled Post Market
CEFTIN	02212307	Marketed

Medicinal ingredients

CEFUROXIME AXETIL 250 MG per TAB
CEFUROXIME AXETIL 500 MG per TAB
CEFUROXIME AXETIL 250 MG per PCK
CEFUROXIME AXETIL 125 MG per 5ML